CVS Health management check

CVS · Health Care · Health Care Services · CEO J. David Joyner

Filings as of

61
Management score, ranked 305th of 487 · 36th of 60 in Health Care4 good · 1 to watch · 1 flaggedStrongest: clean books · Weakest: stable leadership · Best and worst run in Health Care →

Closest peers in Health Care Services

  1. 60CICigna80
  2. 126DVADaVita74
  3. 218DGXQuest Diagnostics67
  4. 223LHLabcorp66
  5. 305CVSCVS Health61
  6. 307TMOThermo Fisher Scientific61

The seven checks

  • Watch

    Have owners done well?

    Trailed its chosen peersOwners$137Peers$148

    What $100 became since fiscal 2021

    4044th
    Detail

    $100 invested at the start of fiscal 2021 grew to $137, against $148 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    8758th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.73 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • n/a

    What does the CEO cost owners?

    Not enough data
    ——

    No pay or net income figure for the latest year.

  • Good

    Do they own the stock?

    Insiders are buying

    6 mo: ▲ $2.0m bought · ▼ $34.6m sold

    8095th
    Detail

    1 insider bought $2.0m on the open market in the last six months, with their own money, near the lows. Sales: $34.6m.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 1.3bn2025 · 1.3bn

    Diluted shares −0.7% a year; flagged above +2%

    0%10%20%

    Stock pay 0.1% of revenue

    5949th
    Detail

    Diluted shares changed -0.7% a year over the last three fiscal years. Stock-based pay was 0.1% of revenue in the latest year.

  • Flag

    Is leadership stable?

    3 CEOs in the pay table

    9 filings under 8-K 5.02 in 3 years

    0101420+

    CEOs: Karen S. Lynch, Larry J. Merlo, J. David Joyner

    04th
    Detail

    CEOs in the pay table: Karen S. Lynch, Larry J. Merlo, J. David Joyner. 9 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed April 3, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$33.2m$66.3m$10020212022202320242025$137$148

Pay tied most to Adjusted Earnings Per Share

Other key measuresAdjusted Operating IncomeTSR

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025J. David Joyner$21.2m$50.5m$10.4m$137$148—
2024J. David Joyner, Karen S. Lynch$23.4m$4.8m$9.8m$74$129—
2023Karen S. Lynch$21.6m$7.5m$9.3m$125$126—
2022Karen S. Lynch$21.3m$23.8m$12.2m$143$124—
2021Karen S. Lynch, Larry J. Merlo$20.4m$66.3m$11.9m$155$126—

Insiders and the CEO's stakeBuying

1 insider bought $2.0m on the open market in the last six months, with their own money, near the lows. Sales: $34.6m.

Open-market trades by officers and directors since May 21, 2026.

  • BoughtPrem S ShahEVP and Group President$2.0mNov 6, 2026
  • SoldLarry RobbinsDirector$34.6mMay 21, 2026

Leadership and governance on file

20222023202420252026Leadership 16Votes 5
All 16 filings

Latest shareholder vote results: May 18, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $24.0bn returned to owners in buybacks and dividends, 89% of net income, and $2.6bn of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$4.2bn$8.3bn20212022202320242025Shares1.33bn1.32bn1.29bn1.26bn1.27bn
Show the figures
Fiscal year20212022202320242025
Revenue$292.1bn$322.5bn$357.8bn$372.8bn$402.1bn
Net income$8.0bn$4.3bn$8.3bn$4.6bn$1.8bn
Stock-based pay$484.0m$447.0m$588.0m$540.0m$535.0m
Buybacks$0$3.5bn$2.0bn$3.0bn$0
Dividends$2.6bn$2.9bn$3.1bn$3.4bn$3.4bn
Diluted shares1329m1323m1290m1262m1271m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.